FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
University of Michigan Rogel Cancer Center
Novartis
Changhai Hospital
Changhai Hospital
University of Kentucky
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Junshi Bioscience Co., Ltd.
Incyte Corporation
GlaxoSmithKline
NYU Langone Health
Zhejiang University
MacroGenics
Ferring Ventures Limited
Sirtex Medical
University of Kentucky
Cordgenics, LLC
Regeneron Pharmaceuticals
Alliance for Clinical Trials in Oncology
Mario Negri Institute for Pharmacological Research
AstraZeneca
University of California, San Francisco
BeiGene
University of Cincinnati
OHSU Knight Cancer Institute
BioLineRx, Ltd.
Daiichi Sankyo
Jiangsu Simcere Pharmaceutical Co., Ltd.
Wake Forest University Health Sciences
Teva Branded Pharmaceutical Products R&D, Inc.
Memorial Sloan Kettering Cancer Center
Jiangsu HengRui Medicine Co., Ltd.
Alliance for Clinical Trials in Oncology
University of Nebraska
University of Florida
Novartis
Henry Ford Health System
pharmaand GmbH
Massachusetts General Hospital
Pfizer
Teva Branded Pharmaceutical Products R&D, Inc.
University of Kentucky
Medical College of Wisconsin
University of Maryland, Baltimore
Bayer
University of Maryland, Baltimore